» Authors » Yuki Matsubara

Yuki Matsubara

Explore the profile of Yuki Matsubara including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 118
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shiraishi K, Okada M, Yamamoto S, Matsubara Y, Masuishi T, Shimozaki K, et al.
Sci Rep . 2025 Mar; 15(1):8031. PMID: 40055515
Cisplatin-based chemotherapy is the standard advanced esophageal squamous cell carcinoma (ESCC) treatment. However, the 5-fluorouracil plus L-leucovorin and oxaliplatin (FOLFOX) regimen is available in Japan as an alternative to cisplatin-based...
2.
Evans M, Krause H, Xiu J, Elliott A, Lou E, Ghani H, et al.
Mod Pathol . 2024 Nov; 38(2):100654. PMID: 39522645
Human epidermal growth factor receptor-2 (HER2) expression is an important biomarker for the management of RAS wild-type metastatic colorectal carcinoma (CRC). Immunohistochemistry (IHC) with reflex in situ hybridization (ISH) is...
3.
Jubashi A, Nakayama I, Koganemaru S, Sakamoto N, Oda S, Matsubara Y, et al.
Gastric Cancer . 2024 Nov; 28(1):63-73. PMID: 39487862
Background: Trastuzumab deruxtecan (T-DXd) is an antibody-drug conjugate targeting HER2-positive gastric cancer or gastroesophageal junction cancer (GC/GEJC). Although effective, T-DXd has notable toxicities, including interstitial lung disease (ILD). This study...
4.
Matsubara Y, Nitta Y, Tanaka K, Ito Y, Adachi N
BMC Musculoskelet Disord . 2024 Aug; 25(1):690. PMID: 39217286
Background: We report a rare case of posterior cruciate ligament (PCL) calcification, which has only been reported in two case studies on PubMed. Case Presentation: A 71-year-old man developed left...
5.
Nakamura Y, Yokoya S, Matsubara Y, Harada Y
Acta Orthop Traumatol Turc . 2024 Aug; 58(3):167-170. PMID: 39165221
The purpose of this study was to identify the relationship between scapula morphology and rotator cuff tears (RCT). Hundred seventeen shoulders with and 87 shoulders without RCTs were included in...
6.
Kodama H, Kadowaki S, Nakazawa T, Matsubara Y, Narita Y, Honda K, et al.
Anticancer Res . 2024 Feb; 44(3):1227-1232. PMID: 38423663
Background/aim: Although gemcitabine plus cisplatin (GC) prolongs survival in patients with recurrent or metastatic nasopharyngeal carcinoma (R/M NPC) compared with fluorouracil plus cisplatin, no study has evaluated the efficacy and...
7.
Ogata T, Narita Y, Oze I, Kumanishi R, Nakazawa T, Matsubara Y, et al.
Ther Adv Med Oncol . 2024 Feb; 16:17588359241229428. PMID: 38344409
Background: Recent trials have reported a median overall survival (OS) of 11-17 months in patients with advanced gastric cancer (AGC). However, it is unclear how recently approved drugs contribute to...
8.
Kobayashi K, Takada N, Matsubara Y, Okuhara H, Oosaka M
J Gen Appl Microbiol . 2024 Jan; 70(2). PMID: 38281752
To enhance the value of surimi, efforts have been made to develop a fermentation method with lactic acid bacteria (LAB) to proteolyze fish protein. However, fermenting unheated surimi poses a...
9.
Matsubara Y, Nakamura Y, Sasashige Y, Yokoya S, Adachi N
J Orthop Surg Res . 2023 Dec; 18(1):952. PMID: 38082411
Background: Few reports exist on the long-term outcomes of midshaft clavicle fracture conservative treatments. Therefore, this study investigated the long-term outcome of this treatment in patients with midshaft clavicle fractures....
10.
Hashimoto S, Yamano M, Yamano T, Zen K, Matsubara Y, Takamatsu K, et al.
Echocardiography . 2023 Nov; 40(12):1374-1382. PMID: 37985209
Background: Residual regurgitation after transcatheter edge-to-edge mitral valve repair (TMVR) is a predictor of poor prognosis in patients with functional mitral regurgitation (FMR). This study sought to identify the mitral...